At a glance
ClinicalIndex Comparison RecordN/ACompleted· 201 enrolled
Drug / intervention
Trevo® Retrieverdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Trevo® Retriever Registry (China)
In Brief
An observational study evaluating Trevo® Retriever for Real World Data in China. Completed, enrolled 201 participants across 10 sites.
Detailed Summary
Trevo® Retriever Registry (China) is to assess real world performance of the FDA cleared Trevo Retriever intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke in China.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsReal World Data in China
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 2018
Enrollment StartJan 2019
Primary CompletionSep 2020
Study CompletionFeb 2021
TodayJul 2026
First PostedJun 13, 2018
Enrollment StartJan 30, 2019
Primary CompletionSep 8, 2020
Study CompletionFeb 2, 2021
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 8.1 years ago
Interventions
Trevo® Retrieverdevice
Stent retriever procedure